期刊
VACCINE
卷 25, 期 42, 页码 7459-7469出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.08.018
关键词
vaccine; ricin; bioterrorism; RiVax
资金
- NIAID NIH HHS [U01 AI056372-01, AI-056372, U01 AI056372-04, U01 AI056372-02, U01 AI056372-03, U01 AI056372] Funding Source: Medline
Ricin is a plant toxin that is a CDC level B biothreat. Our recombinant ricin A chain vaccine (RiVax), which contains mutations in both known toxic sites, has no residual toxicity at doses at least 800 times the immunogenic dose. RiVax without adjuvant given intramuscularly (i.m.) protected mice against intraperitoneally administered ricin. Furthermore the vaccine without alum was safe and immunogenic in human volunteers. Here we describe the development of gavage and aerosol ricin challenge models in mice and demonstrate that i.m. vaccination protects mice against ricin delivered by either route. Also RiVax protects against aerosol-induced lung damage as determined by histology and lung function tests. (c) 2007 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据